D E Newby|D J Webb - JoVE Visualize

Showing results (11-20 of 348) with videos related to

Pageof 35

Sort By:

Circulation|October 31, 2001

Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureF N Witherow, A Helmy, D J Webb, et al.

Journal of the American College of Cardiology|June 17, 1998

Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome XD E Newby, L L Flint, K A Fox, et al.

Scottish Medical Journal|January 12, 2000

Effect of cold exposure, exercise and high altitude on plasma endothelin-1 and endothelial cell markers in manN L Cruden, D E Newby, J A Ross, et al.

QJM : Monthly Journal of the Association of Physicians|January 9, 2009

Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery diseaseB Ilyas, N Dhaun, D Markie, et al.

Hepatology (Baltimore, Md.)|April 3, 2001

Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosisA Helmy, R Jalan, D E Newby, et al.

Gut|January 26, 2006

Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trialD Tripathi, G Therapondos, J W Ferguson, et al.

The Journal of Physiology|May 16, 2000

The influence of heart rate on augmentation index and central arterial pressure in humansI B Wilkinson, H MacCallum, L Flint, et al.

Cardiovascular Research|July 31, 1998

Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systemsD E Newby, R Jalan, S Masumori, et al.

Journal of the American College of Cardiology|November 3, 2001

Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibitionC Labinjoh, D E Newby, M P Pellegrini, et al.

British Journal of Clinical Pharmacology|November 14, 1997

The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstrictionC J Ferro, W G Haynes, N R Johnston, et al.

Pageof 35

Showing results (11-20 of 348) with videos related to

Sort By:

Pageof 35

Circulation|October 31, 2001

Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureF N Witherow, A Helmy, D J Webb, et al.

Journal of the American College of Cardiology|June 17, 1998

Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome XD E Newby, L L Flint, K A Fox, et al.

Scottish Medical Journal|January 12, 2000

Effect of cold exposure, exercise and high altitude on plasma endothelin-1 and endothelial cell markers in manN L Cruden, D E Newby, J A Ross, et al.

QJM : Monthly Journal of the Association of Physicians|January 9, 2009

Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery diseaseB Ilyas, N Dhaun, D Markie, et al.

Hepatology (Baltimore, Md.)|April 3, 2001

Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosisA Helmy, R Jalan, D E Newby, et al.

Gut|January 26, 2006

Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trialD Tripathi, G Therapondos, J W Ferguson, et al.

The Journal of Physiology|May 16, 2000

The influence of heart rate on augmentation index and central arterial pressure in humansI B Wilkinson, H MacCallum, L Flint, et al.

Cardiovascular Research|July 31, 1998

Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systemsD E Newby, R Jalan, S Masumori, et al.

Journal of the American College of Cardiology|November 3, 2001

Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibitionC Labinjoh, D E Newby, M P Pellegrini, et al.

British Journal of Clinical Pharmacology|November 14, 1997

The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstrictionC J Ferro, W G Haynes, N R Johnston, et al.

Pageof 35